Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

Phase 3 Completed 200 enrolled Dipexium Pharmaceuticals, Inc.

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to establish the clinical superiority and the safety of topical pexiganan cream 0.8% plus standard local wound care as compared to placebo cream plus standard local wound care, in the treatment of mildly infected diabetic foot ulcers.

Timeline

Start: 2014-06
Primary completion: 2016-07
Completion: 2016-07

Publications

You Y, Liu H, Zhu Y, Zheng H. Rational design of stapled antimicrobial peptides. Amino Acids. 2023 Apr;55(4):421-442. doi: 10.1007/s00726-023-03245-w. Epub 2023 Feb 12.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MSI-78	Unknown	0.8 %	Topical

Indications

No indication recorded.